| 595 - 604 |
Optimisation of one-step desolvation and scale-up of gelatine nanoparticle production
Geh KJ, Hubert M, Winter G |
| 605 - 612 |
Controlling the morphology and material characteristics of electrospray generated calcium alginate microhydrogels
Nikoo AM, Kadkhodaee R, Ghorani B, Razzaq H, Tucker N |
| 613 - 624 |
Formulation, in vitro evaluation and kinetic analysis of chitosan-gelatin bilayer muco-adhesive buccal patches of insulin nanoparticles
Barzoki ZM, Emam-Djomeh Z, Mortazavian E, Moosavi-Movahedi AA, Tehrani MR |
| 625 - 635 |
In vitro/in vivo evaluation of gamma-aminobutyric acid-loaded N,N-dimethylacrylamide-based pegylated polymeric nanoparticles for brain delivery to treat epilepsy
Kirimlioglu GY, Menceloglu Y, Erol K, Yazan Y |
| 636 - 645 |
Stability study of sodium colistimethate-loaded lipid nanoparticles
Moreno-Sastre M, Pastor M, Esquisabel A, Sans E, Vinas M, Bachiller D, Pedraz JL |
| 646 - 655 |
Polysorbate-80-coated, polymeric curcumin nanoparticles for in vivo anti-depressant activity across BBB and envisaged biomolecular mechanism of action through a proposed pharmacophore model
Yusuf M, Khan M, Khan RA, Maghrabi IA, Ahmed B |
| 656 - 662 |
Magnetic nanogel polymer of bupivacaine for ankle block in rats
Nadri S, Mahmoudvand H, Eatemadi A |
| 663 - 668 |
A pH-responsive asymmetric lipid vesicle as drug carrier
Zhang XN, Zong W, Hu Y, Luo N, Cheng WL, Han XJ |
| 669 - 678 |
Effect of particle size on oral bioavailability of darunavir-loaded solid lipid nanoparticles
Desai J, Thakkar H |
| 679 - 688 |
Comparative study of kanamycin sulphate microparticles and nanoparticles for intramuscular administration: preparation in vitro release and preliminary in vivo evaluation
Mustafa S, Devi VK, Pai RS |
